Cancer Research Cancer Epigenetics  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 5219-5224, September 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinclair, P. R.
Right arrow Articles by Guzelian, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinclair, P. R.
Right arrow Articles by Guzelian, P. S.

Induction of Cytochrome P-450 and 5-Aminolevulinate Synthase Activities in Cultured Rat Hepatocytes1

Peter R. Sinclair2, William J. Bement, Sally A. Haugen, Jacqueline F. Sinclair and Philip S. Guzelian

V. A. Medical Center, White River Junction, Vermont 05001 [P. R. S., W. J. B., S. A. H., J. F. S.]; Department of Biochemistry, Dartmouth Medical School, Hanover, New Hamsphire 03756 [P. R. S., S. A. H., J. F. S.]; and Division of Clinical Toxicology and Environmental Medicine, Department of Medicine, Medical College of Virginia, Richmond, Virginia 23298 [P. S. G.]

Cytochromes P-450IIB1 and P-450IIB2 were recently shown to be inducible in rat hepatocyte cultures maintained on a reconstituted extracellular tumor matrix (Matrigel) as indicated by increases in P-450IIB1 and -IIB2 mRNAs and immunoreactive proteins (J. Cell. Physiol., 134: 309–323, 1988). Here we show that treatment of cultured rat hepatocytes with phenobarbital and other compounds known to induce P-450IIB1/2 in vivo increased spectral cytochrome P-450, immunoreactive proteins, and benzyloxy- and pentoxy-resorufin dealkylases, activites known to be specific for cytochrome P-450IIB1/2. These increases were observed when cells were cultured on either Matrigel or collagen matrix in Williams E medium. Cytochrome P-450III was also increased by phenobarbital and dexamethasone on either matrix. Propoxycoumarin depropylase activity, which has been proposed as a specific activity catalyzed by cytochrome P-450III, was increased 3–4-fold more by treatment with 3-methylcholanthrene than by phenobarbital or dexamethasone. The activity catalyzed by P-450III could be distinguished from that catalyzed by other P-450 forms using the specific inhibitor triacetyloleandomycin. Benzoyloxyresorufin dealkylase was also increased in these cells by treatment with 2,4,5,2',4',5'-hexachlorobiphenyl, glutethimide, or mephenytoin. Treatment with phenobarbital or 2-allyl-2-isopropylacetamide slightly induced 5-aminolevulinate synthase activity. 5-Aminolevulinate synthase activity was slightly increased in cells treated with phenobarbital or 2-allyl-2-isopropylacetamide. Succinyl acetone also induced 5-aminolevulinate synthase activity and, in combination with either of the other two drugs, synergistically increased the enzyme activity regardless of whether cells were cultured on collagen or Matrigel. These results indicate that with simple and economical enzyme assays for bolocytochrome P-450 and 5-aminolevulinate synthase, the rat hepatocyte culture system can be used for studies of the interrelationships between phenobarbital induction of cytochrome P-450 and heme metabolism.

1 Supported by USPHS Grants CA25012 and AA07146.

2 To whom requests for reprints should be addressed, at VA (151), White River Junction, VT 05001.

Received 12/29/89. Revised 5/ 9/90.


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
T. L. Noreault, V. E. Kostrubsky, S. G. Wood, R. C. Nichols, S. C. Strom, H. W. Trask, S. A. Wrighton, R. M. Evans, J. M. Jacobs, P. R. Sinclair, et al.
ARSENITE DECREASES CYP3A4 AND RXR{alpha} IN PRIMARY HUMAN HEPATOCYTES
Drug Metab. Dispos., July 1, 2005; 33(7): 993 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. M. Silva, P. E. Morin, S. H. Day, B. P. Kennedy, P. Payette, T. Rushmore, J. A. Yergey, and D. A. Nicoll-Griffith
Refinement of an in Vitro Cell Model for Cytochrome P450 Induction
Drug Metab. Dispos., May 1, 1998; 26(5): 490 - 496.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Stoltz, M.-H. Vachon, E. Trottier, S. Dubois, Y. Paquet, and A. Anderson
The CYP2B2 Phenobarbital Response Unit Contains an Accessory Factor Element and a Putative Glucocorticoid Response Element Essential for Conferring Maximal Phenobarbital Responsiveness
J. Biol. Chem., April 3, 1998; 273(14): 8528 - 8536.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
O. Khatsenko and Y. Kikkawa
Nitric Oxide Differentially Affects Constitutive Cytochrome P450 Isoforms in Rat Liver
J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1463 - 1470.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.